Browse articles from EyeWorld.org related to keratoconus. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

EyeWorld Weekly, June 6, 2025

➤ FDA approves first-in-class DED drop ➤ FDA accepts NDA for topical presbyopia therapy ➤ TFOS DEWS III ➤ Topline results in Phase 3 study evaluating night driving impairment after keratorefractive surgery ➤ IND application submitted for pediatric myopia treatment ➤ Study sheds light on clinical inherited retinal diseases without genetic mutations ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, June 6, 2025

EyeWorld Weekly, March 28, 2025

➤ Voluntary IOL recall ➤ Phase 4 study assesses patient-reported outcomes of dry eye drop ➤ Study: synthetic opsin restores vision in cases of severe retinal degeneration ➤ Phase 3 endpoints not met in trial evaluating wet AMD treatment ➤ Merger news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, March 28, 2025

EyeWorld Weekly, March 21, 2025

➤ Study: long-term efficacy of uveoscleral outflow enhancement for glaucoma ➤ FDA grants expanded indication for fluocinolone acetonide intravitreal implant ➤ First patient dosed in Phase 1/2 gene therapy trial targeting Stargardt disease ➤ Merger complete ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, March 21, 2025

EyeWorld Weekly, February 28, 2025

➤ ASCRS EyeWorld Weekly: View the current issue ➤ Transepithelial crosslinking NDA submission accepted ➤ Fast Track designation granted to drop being investigated for night driving impairment due to visual disturbances ➤ First-in-human interventional study for gene therapy treating Leber congenital amaurosis 4 ➤ Positive outcomes observed for geographic atrophy drug ➤ Regenerative Medicine Advanced Therapy designation granted to stem cell therapy for dry AMD ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, February 28, 2025

EyeWorld Weekly, December 13, 2024

➤ Topline results for non-steroidal immunomodulator for postop inflammation ➤ Pilot study describes use of prosthetic device for treatment of dry eye ➤ First patient dosed in Phase 3 trial investigating wet AMD treatment ➤ Acquisition and partnership news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, December 13, 2024

Crosslinking: then, now, and next up

With new techniques in (or having recently completed) Phase 3 clinical trials to potentially move crosslinking to the next stage in the U.S., EyeWorld spoke with specialists to look back at where keratoconus monitoring and treatment was, where it is now, and what could be coming.

Comments Off on Crosslinking: then, now, and next up

Cataract surgery in patients with keratoconus

When performing cataract surgery in patients with keratoconus, there are considerations for surgical planning, lenses, and techniques that surgeons need to account for to ensure success. Two ophthalmologists discussed how they handle these patients, including testing, formulas, and IOL selection.

Comments Off on Cataract surgery in patients with keratoconus

EyeWorld Journal Club review: “Prediction of the small aperture intraocular lens on visual acuity in patients with keratoconus”

The Cullen Eye Institute residents reviewed “Prediction of the small aperture intraocular lens on visual acuity in patients with keratoconus” from the Journal of Cataract & Refractive Surgery.

Comments Off on EyeWorld Journal Club review: “Prediction of the small aperture intraocular lens on visual acuity in patients with keratoconus”

EyeWorld Weekly, December 15, 2023

➤ Positive topline results in Phase 2a trial for treatment of MGD in patients with Demodex ➤ First patient visit in Phase 2b trial evaluating anti-TNFα for dry eye disease ➤ Smart contact lens makes progress ➤ Asset transition ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, December 15, 2023